Microorganisms (Nov 2022)

Development of a Real-Time Recombinase-Aided Amplification Method to Rapidly Detect Methicillin-Resistant <i>Staphylococcus aureus</i>

  • Xiaoyan Ding,
  • Hejia Wang,
  • Mingquan Cui,
  • Min Cheng,
  • Qi Zhao,
  • Yuhui Bai,
  • Chunping Zhang,
  • Cunshuai Zhang,
  • Shixin Xu,
  • Ting Li

DOI
https://doi.org/10.3390/microorganisms10122351
Journal volume & issue
Vol. 10, no. 12
p. 2351

Abstract

Read online

Methicillin-resistant staphylococcus aureus (MRSA) is a major pathogen responsible for human hospital and community-onset diseases and severe invasive livestock infections. Rapid detection of MRSA is essential to control the spread of MRSA. Conventional identification methods and antibacterial susceptibility tests of MRSA are time-consuming. The commonly used qPCR assay also has the disadvantages of being complicated and expensive, restricting its application in resource-limited clinical laboratories. Here, a real-time fluorescent recombinase-assisted amplification (RAA) assay targeting the most conserved regions within the mecA gene of MRSA was developed and evaluated to detect MRSA. The detection limit of this assay was determined to be 10 copies/reaction of positive plasmids. The established RAA assay showed high specificity for MRSA detection without cross-reactivities with other clinically relevant bacteria. The diagnostic performance of real-time RAA was evaluated using 67 clinical S. aureus isolates from dairy farms, which were detected in parallel using the TaqMan probe qPCR assay. The results showed that 56 and 54 samples tested positive for MRSA by RAA and qPCR, respectively. The overall agreement between both assays was 97.01% (65/67), with a kappa value of 0.9517 (p R2 = 0.9012, p < 0.0001), indicating that this RAA assay possesses similar detection performance to the qPCR assay. In conclusion, our newly established RAA assay is a time-saving and convenient diagnostic tool suitable for MRSA detection and screening.

Keywords